Inflammatory bowel diseases (IBD), which commonly include Crohn’s disease and ulcerative colitis, are characterized by gastrointestinal symptoms, but they can also manifest in extraintestinal complications in up to 20% of cases, predominantly in the oral cavity and in the joints.
Oral manifestations predominate in patients with Crohn’s disease, and with higher incidence in male sex and in children. They can appear at any time during the development of systemic disease, even before intestinal manifestations.
The most common lesions with canker sores (ulcers or more or less small whitish and painful wounds usually located in the mucosa, gum or palate), but granulomatous lesions can also appear, as a “cobblestone” appearance, with a histology similar to the intestine. They usually appear in the mucovestibular fold, which looks lobulated, hypertrophic, edematous, fissured, with or without linear ulcers. They can recur (ie, disappear and reappear) in different ways and locations, remit and exacerbate (worsen) in relation or not to bowel symptoms.
Early diagnosis of an oral lesion is important because it may be a localized clinical sign of a systemic disease. In some people intestinal symptoms may be minimal or underactile, therefore, in those patients in whom these changes occur in the mouth, should be suspected intestinal disease even in the absence of specific symptoms.
For all this it is important to emphasize that an important follow-up by your dentistry specialist, hence the importance of periodic reviews, will allow you to detect any type of injury early and also improve your oral health, so intrinsically linked to your general health. Taking into account this consideration, your dentist will provide you with the best tools and recommend the best prevention techniques. For this, has the best advances in the field of genetics, which, through a simple sample of saliva, available with the genetic test of tellmeGen, allows us to know the predisposition to various general diseases and oral cavity manifestations such as inflammatory bowel disease.
Advancing towards Precision Medicine takes on a vital importance when it comes to improving and optimizing pharmacological treatments, achieving individualization to achieve excellence. In addition, it is important to know the individual predisposition, since diseases with a genetic load will allow us to face them in a more active and efficient way.